Drug
Regadenoson
Regadenoson: highest development phase Not Applicable, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| regadenoson NCT01026012 | Not Applicable | Cardiac Function |
Latest
No recent events.
Follow Regadenoson on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.